Joseph Frank Oldakowski sold $103k of CLOV
VP OF FINANCE AND CONTROLLER at CLOVER HEALTH INVESTMENTS, CORP. /DE. 20,000 shares at an average of $5.16, traded Sep 14, 2026, filed Sep 14, 2026.
Score components
- +15RoleOfficer
- +10Trade size$103k at market
- 0Share of holdings soldSold 6.7% of holdings
- +15Cluster4 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001801170-26-000218, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | SOpen-market sale Class A Common Stock | -20,000 | $5.16 | $103k | 279,067 | 29 d ago |
Related signals
Other insiders at CLOVER HEALTH INVESTMENTS, CORP. /DE and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 13Weak | CLOVER HEALTH INVESTMENTS, CORP. /DE | Jamie L. Reynoso CEO, Medicare Advantage | $9,288 2,006 shares | -0% | |
| 19Weak | CLOVER HEALTH INVESTMENTS, CORP. /DE | Jamie L. Reynoso CEO, Medicare Advantage | $39k 8,750 shares | -0% | |
| 38Weak | CLOVER HEALTH INVESTMENTS, CORP. /DE | Andrew Toy Chief Executive Officer | $1.3M 318,806 shares | -3% | |
| 20Weak | CLOVER HEALTH INVESTMENTS, CORP. /DE | Jamie L. Reynoso CEO, Medicare Advantage | $8,760 1,921 shares | -0% | |
| 10Weak | CLOVER HEALTH INVESTMENTS, CORP. /DE | Joseph Frank Oldakowski VP OF FINANCE AND CONTROLLER | $15k 3,170 shares | -1% | |
| 50Moderate | CLOVER HEALTH INVESTMENTS, CORP. /DE | Conrad Wai CEO, Counterpart Health | $1.4M 300,000 shares | -20% | |
| 26Weak | CLOVER HEALTH INVESTMENTS, CORP. /DE | Jamie L. Reynoso CEO, Medicare Advantage | $44k 9,273 shares | -0% | |
| 16Weak | CLOVER HEALTH INVESTMENTS, CORP. /DE | Karen Soares Chief Legal Officer | $33k 6,846 shares | -0% | |
| 19Weak | CLOVER HEALTH INVESTMENTS, CORP. /DE | Joseph Clay Thornton Interim CFO | $78k 17,775 shares | -1% | |
| 29Weak | CLOVER HEALTH INVESTMENTS, CORP. /DE | Andrew Toy Chief Executive Officer | $408k 87,798 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.